{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:08:08Z","timestamp":1777867688758,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019270","name":"Fundaci\u00f3n Marqu\u00e9s de Valdecilla","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI050427"],"award-info":[{"award-number":["PI050427"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI060507"],"award-info":[{"award-number":["PI060507"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI020499"],"award-info":[{"award-number":["PI020499"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CI 2005-0308007"],"award-info":[{"award-number":["CI 2005-0308007"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.pnpbp.2019.109677","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T03:52:24Z","timestamp":1561002744000},"page":"109677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients"],"prefix":"10.1016","volume":"95","author":[{"given":"Javier","family":"V\u00e1zquez-Bourgon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Ortiz-Garc\u00eda de la Foz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Suarez-Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Iruzubieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Arias-Loste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Seti\u00e9n-Suero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Ayesa-Arriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"G\u00f3mez-Revuelta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedicto","family":"Crespo Facorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pnpbp.2019.109677_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176416","article-title":"Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: a cross-sectional study","volume":"12","author":"Adejumo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.109677_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13696","article-title":"Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease","author":"Adejumo","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.pnpbp.2019.109677_bb0015","doi-asserted-by":"crossref","first-page":"9430953","DOI":"10.1155\/2018\/9430953","article-title":"Reduced incidence and better liver disease outcomes among chronic HCV infected patients who consume cannabis","volume":"2018","author":"Adejumo","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109677_bb0020","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109677_bb0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/cap.2017.0117","article-title":"One-year prospective study of liver function tests in children and adolescents on second-generation antipsychotics: is there a link with metabolic syndrome?","volume":"28","author":"Baeza","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2019.109677_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109677_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109677_bb0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/cit378","article-title":"Canadian co-infection cohort investigators. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis","volume":"57","author":"Brunet","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109677_bb9057","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0269881116631652","article-title":"Bartels[HYPHEN]Velthuis AA, Visser E, van den Heuvel ER, Bruggeman R, J\u00f6rg F. Cannabis use in people with severe mental illness: The association with physical and mental health-a cohort study. A Pharmacotherapy Monitoring and Outcome Survey study","volume":"30","author":"Bruins","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2019.109677_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1360-0443.97.s01.1.x","article-title":"Cannabis use: consistency and validity of selfreport, on-site urine testing and laboratory testing","volume":"97","author":"Buchan","year":"2002","journal-title":"Addiction."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109677_bb0055","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrd2553","article-title":"Targeting the endocannabinoid system: to enhance or reduce?","volume":"7","author":"Di Marzo","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109677_bb0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"Elsohly","year":"2005","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109677_bb0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.pnpbp.2007.12.032","article-title":"Risperidone and liver function tests in children and adolescents: a short-term prospective study","volume":"32","author":"Erdogan","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109677_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109677_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cld.2015.10.009","article-title":"Current pharmacologic therapy for nonalcoholic fatty liver disease","volume":"20","author":"Ganesh","year":"2016","journal-title":"Clin. Liver Dis."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109677_bb0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/WNF.0b013e3181f0ec33","article-title":"Visceral and subcutaneous fat in patients treated with olanzapine: a case series","volume":"33","author":"Gilles","year":"2010","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109677_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2019.109677_bb0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.187.4.306","article-title":"Cannabis use and misuse prevalence among people with psychosis","volume":"187","author":"Green","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109677_bb0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/00952999309001632","article-title":"Self-reported drug use data: what do they reveal?","volume":"19","author":"Harrison","year":"1993","journal-title":"Am. J. Drug Alcohol Abuse."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109677_bb0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2007.11.039","article-title":"Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C","volume":"134","author":"H\u00e9zode","year":"2008","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109677_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2011.09.002","article-title":"Phytocannabinoids as novel therapeutic agents in CNS disorders","volume":"133","author":"Hill","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109677_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/dom.12447","article-title":"A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis","volume":"17","author":"Hsiao","year":"2015","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109677_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.psym.2013.06.001","article-title":"Increased risk of chronic liver disease in patients with schizophrenia: a population-based cohort study","volume":"55","author":"Hsu","year":"2014","journal-title":"Psychosomatics."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109677_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cgh.2007.10.021","article-title":"Influence of cannabis use on severity of hepatitis C disease","volume":"6","author":"Ishida","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109677_bb0125","first-page":"10","article-title":"A six-to-ten weeks' follow-up study on the effects of olanzapine on abdominal fat and other metabolic parameters in patients with psychoses--an imaging-based study with controls","volume":"21","author":"Joseph","year":"2011","journal-title":"East Asian Arch. Psychiatry."},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109677_bb0135","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00213-017-4598-5","article-title":"Body and liver fat content and adipokines in schizophrenia: a magnetic resonance imaging and spectroscopy study","volume":"234","author":"Kim","year":"2017","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.pnpbp.2019.109677_bb0130","doi-asserted-by":"crossref","first-page":"e0186702","DOI":"10.1371\/journal.pone.0186702","article-title":"Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.109677_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-244X-14-35","article-title":"Visceral obesity in normal-weight patients suffering from chronic schizophrenia","volume":"14","author":"Konarzewska","year":"2014","journal-title":"BMC Psychiatry."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109677_bb0145","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nm0606-608","article-title":"Cannabinoids hurt, heal in cirrhosis","volume":"12","author":"Kunos","year":"2006","journal-title":"Nat. Med."},{"issue":"30","key":"10.1016\/j.pnpbp.2019.109677_bb0150","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.pnpbp.2019.109677_bb0155","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/sj.ijo.0802753","article-title":"Obesity, leptin resistance, and the effects of insulin reduction","volume":"28","author":"Lustig","year":"2004","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109677_bb0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1358\/dnp.2008.21.7.1255306","article-title":"Cannabinoid receptors as therapeutic targets in the management of liver diseases","volume":"21","author":"Mallat","year":"2008","journal-title":"Drug News Perspect."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109677_bb0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/14728222.11.3.403","article-title":"Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases","volume":"11","author":"Mallat","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109677_bb0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1590\/1516-4446-2017-2231","article-title":"Gender differences of cannabis smoking on serum leptin levels: population-based study","volume":"40","author":"Moreira","year":"2018","journal-title":"Braz. J. Psychiatr."},{"issue":"23\u201324","key":"10.1016\/j.pnpbp.2019.109677_bb0175","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1007\/s00213-016-4422-7","article-title":"Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study","volume":"233","author":"Morl\u00e1n-Coarasa","year":"2016","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109677_bb0180","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2337\/dc12-2303","article-title":"Metabolic effects of chronic cannabis smoking","volume":"36","author":"Muniyappa","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109677_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jvh.12797","article-title":"Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH)","volume":"25","author":"Nordmann","year":"2018","journal-title":"J. Viral Hepat."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109677_bb0190","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109677_bb0195","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109677_bb0200","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1751-7893.2008.00074.x","article-title":"Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the clinical programme on early phases of psychosis","volume":"2","author":"Pelayo-Ter\u00e1n","year":"2008","journal-title":"Early Interv. Psychiatry."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109677_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/JCP.0b013e318172b8e6","article-title":"Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment","volume":"28","author":"Perez-Iglesias","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109677_bb0210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addict. Biol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109677_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2631","article-title":"Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: an updated meta-analysis","volume":"32","author":"Ragguett","year":"2017","journal-title":"Hum. Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109677_bb0220","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.pnpbp.2019.109677_bb0225","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2018.02.050","article-title":"Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders","volume":"199","author":"Scheffler","year":"2018","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109677_bb0230","doi-asserted-by":"crossref","first-page":"e0183613","DOI":"10.1371\/journal.pone.0183613","article-title":"Cannabis use in male and female first episode of non-affective psychosis patients: long-term clinical, neuropsychological and functional differences","volume":"12","author":"Seti\u00e9n-Suero","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109677_bb0235","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jhep.2015.01.001","article-title":"Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis","volume":"62","author":"Silvestri","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.pnpbp.2019.109677_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuro.2017.08.012","article-title":"Changes in the cannabinoids receptors in rats following treatment with antidepressants","volume":"63","author":"Smaga","year":"2017","journal-title":"Neurotoxicology."},{"key":"10.1016\/j.pnpbp.2019.109677_bb0245","series-title":"Translational Pain Research: From Mouse to Man","article-title":"Therapeutic targeting of peripheral cannabinoid receptors in inflammatory and neuropathic pain states","author":"Spigelman","year":"2010"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109677_bb0250","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109677_bb0255","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.24077","article-title":"Endocannabinoids in liver disease","volume":"53","author":"Tam","year":"2011","journal-title":"Hepatology."},{"key":"10.1016\/j.pnpbp.2019.109677_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-5491.2007.02025.x","article-title":"Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens","volume":"24","author":"Targher","year":"2007","journal-title":"Diabet. Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109677_bb0265","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109677_bb0270","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-017-4763-x","article-title":"Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-na\u00efve patients with a first-episode of psychosis","volume":"235","author":"V\u00e1zquez-Bourgon","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2019.109677_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.104415","article-title":"Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis","author":"V\u00e1zquez-Bourgon","year":"2019","journal-title":"Data in Brief"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109677_bb0280","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/0269881118822173","article-title":"Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: results from a 3-years longitudinal study","volume":"33","author":"V\u00e1zquez-Bourgon","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2019.109677_bb0285","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/NDT.S137183","article-title":"The prevalence and risk factors of young male schizophrenics with non-alcoholic fatty liver disease","volume":"13","author":"Yan","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619301393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619301393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:40:43Z","timestamp":1777545643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619301393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":57,"alternative-id":["S0278584619301393"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109677","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109677"}}